3D Bio-Tissues is pleased to announce a major new commercial milestone for ETSYL®, its proprietary bioactive peptide originally developed through the company’s tissue engineering research. BSF Enterprise PLC has signed Heads of Terms with SCHAKAU Managementberatung GmbH for the worldwide exclusive commercialisation, distribution and licensing of ETSYL® across the cosmetics, skincare, dermocosmetics and luxury beauty sectors. For 3D Bio-Tissues, the agreement represents an important step in...

The 3DBT portfolio available via CellBase includes: CytoBoost™ A chemically defined, xeno-free range of media additives designed to replicate macromolecular crowding in native in vivo environments, supporting improved cell performance, consistency and reproducibility across a wide range of cell culture applications. The CytoBoost™ range includes: • CytoBoost™ PERFORM : supports robust day-to-day cell culture by enhancing cell health and functional performance across routine research...

SeaWith is incorporating City-Mix®, 3DBT’s proprietary macromolecular crowder media additive, into its cultivated beef development programme. The use of City-Mix® is designed to enhance cell growth efficiency while reducing overall media consumption, a key cost driver in cultivated meat production.